- VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
- VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
- Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
- Volition appoints Dr Andrew Retter as Chief Medical Officer
- Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
- Volition Issues Business Review 2023
More ▼
Key statistics
On Wednesday, VolitionRX Ltd (VNRX:ASQ) closed at 0.743, 35.09% above the 52 week low of 0.55 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.738 |
---|---|
High | 0.77 |
Low | 0.70 |
Bid | 0.68 |
Offer | 0.82 |
Previous close | 0.743 |
Average volume | 210.97k |
---|---|
Shares outstanding | 82.07m |
Free float | 62.28m |
P/E (TTM) | -- |
Market cap | 60.98m USD |
EPS (TTM) | -0.504 USD |
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
More ▼